What is the current price and activity level for 4564.T stock?

4564.T stock is trading at **JPY 22.00** intraday on 19 Mar 2026 with volume **53,956,400.00**, a relative volume of **2.14**, making it one of JPX's most active names today.

What valuation metrics matter for 4564.T stock?

Key metrics: EPS **-2.83**, PE **-8.13**, price-to-book **3.88**, cash per share **6.06**, and current ratio **8.51**. These highlight a cash-rich, loss-making biotech profile focused on R&D.

What does Meyka AI forecast mean for 4564.T stock?

Meyka AI's forecast model projects a yearly price of **JPY 17.31**, implying **-21.23%** from the current **JPY 22.00**. Forecasts are model-based projections and not guarantees.

What are the main risks for traders in 4564.T stock?

Main risks include clinical trial setbacks, earnings volatility, and event-driven swings. Although debt is low, profitability is negative and investor positions can move sharply around trial news.

JP Stocks

4564.T stock OncoTherapy JPX JPY 22.00 on 19 Mar 2026: heavy volume drives intraday focus

ByDanny Kontos March 19, 2026

4564.T stock is trading at JPY 22.00 intraday on the JPX on 19 Mar 2026 after a one-day fall of -4.35% on heavy volume. Traders have exchanged 53,956,400.00 shares today, more than twice the average, making OncoTherapy Science, Inc. one of the most active names on the board. The move tracks mixed clinical progress, a tight cash buffer per share, and technical indicators showing short-term momentum. This intraday note gives price, volume, valuation and a concise outlook for intraday traders and longer-term investors.